← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

A

$ Value

$0

Shares

48,375

Price

$0

Filed

Feb 23

Insider

Name

Williams Sarah Joanne

Title

Principal Accounting Officer

CIK

0002108922

Roles

Officer

Transaction Details

Transaction Date

2026-02-20

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

67,175

Footnotes

Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. | Includes the balance of (a) 10,938 RSUs which vest as follows: 1/4th of the RSUs vest in substantially equal installments annually (rounded down to the nearest whole number of shares) over four years from January 1, 2025, and (b) 11,850 RSUs which vest as follows: 1/16th of the RSUs vest in substantially equal installments quarterly (rounded down to the nearest whole number of shares) over four years from May 28, 2024, in each case subject to the Reporting Person's continuous service through each applicable vesting date. A total of 3,174 shares from the aggregate number of the RSUs issued under (a) and (b) above were sold to cover taxes and a total of 814 shares were sold on the open market.

Filing Info

Accession No.

0001193125-26-064166

Form Type

4

Issuer CIK

0001880438

Williams Sarah Joanne's History

Date Ticker Type Value
2026-03-03 ANTX $347
2026-02-20 ANTX A $0

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03